{"id":14135,"date":"2011-09-30T12:31:51","date_gmt":"2011-09-30T16:31:51","guid":{"rendered":"http:\/\/1boringoldman.com\/?p=14135"},"modified":"2011-09-30T13:18:17","modified_gmt":"2011-09-30T17:18:17","slug":"corner-on-the-market","status":"publish","type":"post","link":"https:\/\/1boringoldman.com\/index.php\/2011\/09\/30\/corner-on-the-market\/","title":{"rendered":"corner on the market&#8230;"},"content":{"rendered":"<br \/>\n<blockquote>\n<div align=\"center\"><a target=\"_blank\" href=\"http:\/\/www.theaustralian.com.au\/news\/health-science\/dispute-as-mcgorry-complaint-dismissed\/story-e6frg8y6-1226152300982\"><u><strong><font color=\"#200020\">Dispute as McGorry complaint dismissed<\/font><\/strong><\/u><\/a><br \/>           <strong><font color=\"#200020\">The Australian<\/font><\/strong><br \/>           by Stuart Rintoul<br \/>           September 30, 2011<\/div>\n<p align=\"justify\"><sup>A complaint against former Australian of the Year Patrick McGorry  for planning a trial of drugs on children has been dismissed. But the 13 international health experts who lodged the complaint  with the ethics committee at Melbourne Health calling for the trial to  be abandoned say they are dissatisfied with the finding and have lodged a  complaint against the ethics committee. Geoff Stuart from La  Trobe University&#8217;s school of psychological sciences, who signed the  complaint, said there were concerns about the circumstances in which the  proposed trial was aborted that deserved to be examined. He said  the &quot;derisory and dismissive&quot; one-sentence response of the ethics  committee fell well short of explaining the &quot;huge error&quot; that was made  in approving the trial.<\/sup><\/p>\n<p align=\"justify\"><sup>Professor McGorry, executive director of  the Orygen Research Centre and one of the Prime Minister&#8217;s key mental  health advisers, planned to trial the effectiveness of the drug  Quetiapine on patients &quot;who are deemed at risk of developing a psychotic  disorder&quot;, listing it on the Australian New Zealand Clinical Trials  Registry last March. The trial, funded by the drug&#8217;s manufacturer, was to investigate  whether it would decrease or delay the risk of people between 15 and 40  with early signs of mental illness developing a psychotic disorder such  as schizophrenia.<\/sup><\/p>\n<p align=\"justify\"><sup>On July 31, 13 psychiatrists, psychologists and  researchers from Australia, New Zealand, Canada, Britain and the US  objected to the trial for reasons including &quot;the ethics of causing  unnecessary harm to individuals not requiring treatment, to possibly  prevent harm to a smaller number who do require treatment&quot;. Professor  McGorry said last night the study was approved by the ethics committee  after a &quot;very rigorous process&quot; before being &quot;reluctantly&quot; abandoned in  June, when it was decided to proceed with a more promising trial  involving fish oil. &quot;As far as I&#8217;m concerned, the trial isn&#8217;t  going ahead &#8211; it was ethically approved to do so, the committee has  considered the complaint very carefully and has made a decision,&quot; he  said. He said the complaint against the trial was &quot;able to be defended on every level&quot;.<\/sup><\/p>\n<div align=\"justify\"><sup>But Associate Professor Stuart said there was a lack of transparency in how such a controversial trial was ethically approved. He  said Professor McGorry&#8217;s plan to use anti-psychotic drugs on children  as young as 15 had &quot;raised alarm bells around the world&quot;. Melbourne  Health said last night its mental health research ethics committee was  &quot;satisfied the process and the decision to give ethics committee  approval of the study were appropriate&quot;. The health organisation said the study had been abandoned by the research team for &quot;logistical reasons&quot;.<\/sup><\/div>\n<\/blockquote>\n<div align=\"justify\">In a rational world, seniority or celebrity is no reason for immunity in matters ethical. And in this story, the complaint is that this Clinical Trial shouldn&#8217;t have been approved by the ethics committee of Melbourne Health in the first place. I suppose that McGorry could argue that there have already been three trials where medicating the ultra high risk group with Atypical Antipsychotics had apparently been approved by ethics committees in industry-financed drug trials:<\/div>\n<ol>\n<li>\n<div align=\"justify\"><strong><u><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12365879\" target=\"_blank\"><font color=\"#200020\">Randomized    controlled trial of interventions designed to reduce the risk of    progression to first-episode psychosis in a clinical sample with    subthreshold symptoms<\/font><\/a><\/u><\/strong>. <strong><font color=\"#200020\">Archives of General Psychiatry.<\/font><\/strong> <strong><font color=\"#990000\">2002<\/font><\/strong> 59(10):921-8. [<strong><u><a href=\"http:\/\/archpsyc.ama-assn.org\/cgi\/content\/full\/59\/10\/921\" target=\"_blank\"><font color=\"#200020\">full text on-line<\/font><\/a><\/u><\/strong>]<\/div>\n<\/li>\n<li>\n<div align=\"justify\"><strong><u><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19670055\" target=\"_blank\"><font color=\"#200020\">Randomized   controlled trial of interventions for young people at ultra-high risk   of psychosis: study design and baseline characteristics<\/font><\/a><\/u><\/strong>. <strong><font color=\"#200020\">Aust NZ Journal of Psychiatry<\/font><\/strong>. <strong><font color=\"#990000\">2009<\/font><\/strong> 43(9):818-29.<\/div>\n<div align=\"justify\"><strong><u><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21034687\" target=\"_blank\"><font color=\"#200020\">Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis<\/font><\/a><\/u><\/strong>. <strong><font color=\"#200020\">Journal of Clinical Psychiatry<\/font><\/strong>. <strong><font color=\"#990000\">2011<\/font><\/strong> 72(4):430-40.<\/div>\n<\/li>\n<li>\n<div align=\"justify\"><a target=\"_blank\" href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16648318\"><u><strong><font color=\"#200020\">Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis<\/font><\/strong><\/u><\/a>. <strong><font color=\"#200020\">American Journal of Psychiatry<\/font><\/strong>. <strong><font color=\"#990000\">2006<\/font><\/strong> 163(5):790-9. [<a href=\"http:\/\/ajp.psychiatryonline.org\/cgi\/content\/full\/163\/5\/790\" target=\"_blank\"><u><strong><font color=\"#200020\">full text online<\/font><\/strong><\/u><\/a>]<\/div>\n<\/li>\n<\/ol>\n<div align=\"justify\">The other side of that argument would be that the first two studies were initiated around 2000 when the toxicity of the drugs was largely unknown, and that is somewhat true of the third study. Likewise, none of the studies reported data suggesting that the medication was very helpful. Why do it again?    <\/div>\n<p align=\"justify\">But, perhaps the most compelling argument against approving this trial was made by Dr. McGorry himself in his patent application for Omega-3 Fatty Acids:  <\/p>\n<table width=\"95%\" cellspacing=\"0\" cellpadding=\"5\" border=\"0\" align=\"center\">\n<tr>\n<td align=\"justify\"><strong><font color=\"#990000\">However, the use of antipsychotic medication for  indicated prevention remains controversial even in research settings  because of the high number of false positives [about 70-80% of people  who meet ultra-high-risk criteria do not progress to psychotic disorder  within one year]. Stigmatization associated with the use antipsychotics,  and unwanted side effects which include metabolic changes, sexual  dysfunction and weight gain are often not acceptable. Other side effects  may include dyslipidaemia, cardiac arrhythmia and osteoporosis. <\/font><\/strong><\/td>\n<\/tr>\n<tr>\n<td align=\"right\"><em><u><a target=\"_blank\" href=\"http:\/\/www.freepatentsonline.com\/y2011\/0166229.html\"><strong><font color=\"#200020\">Prevention of Psychotic Disorders and\/or Treatment of Pychotic Symptoms<\/font><\/strong><\/a><\/u><\/em> <\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\"><img loading=\"lazy\" decoding=\"async\" width=\"180\" vspace=\"6\" hspace=\"4\" height=\"135\" border=\"1\" align=\"right\" src=\"http:\/\/wordsmith.org\/words\/images\/achilles_heel.jpg\" \/>The <a target=\"_blank\" href=\"http:\/\/images.smh.com.au\/file\/2011\/08\/20\/2570828\/mcgorryletter.pdf?rand=1313848888928\"><u><strong><font color=\"#200020\">letter to the ethics committee<\/font><\/strong><\/u><\/a> is well-written, clear in scope, and deserves a full public hearing not just for this instance, but for the ones that will follow. I&#8217;ve already commented on Dr. McGorry&#8217;s disdainful and self righteous way of dealing with critics [<u><strong><a href=\"http:\/\/1boringoldman.com\/index.php\/2011\/09\/06\/the-internal-critic\/\" target=\"_blank\"><font color=\"#200020\">the internal critic&hellip;<\/font><\/a><\/strong><\/u>, <u><strong><a href=\"http:\/\/1boringoldman.com\/index.php\/2011\/09\/25\/hubris-5\/\" target=\"_blank\"><font color=\"#200020\">hubris&hellip;<\/font><\/a><\/strong><\/u>] as well as his eloquence [<u><strong><a href=\"http:\/\/1boringoldman.com\/index.php\/2011\/09\/06\/speaking-of-patrick-mcgorry\/\" target=\"_blank\"><font color=\"#200020\">speaking of Patrick McGorry&hellip;<\/font><\/a><\/strong><\/u>]. He appears to be one of those people with a true <strong><font color=\"#660033\">Achilles Heel<\/font><\/strong>, an inability to listen to criticism and learn from it. Instead, he interprets his critics as attacking him personally and becomes haughty or retaliates sarcastically. It will be his downfall if he&#8217;s not careful. <\/p>\n<div align=\"justify\">He hasn&#8217;t realized that those of us who criticize some of his choices want to help young mentally ill people too. We&#8217;re actually on his side. He doesn&#8217;t have a corner on the market&#8230;<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Dispute as McGorry complaint dismissed The Australian by Stuart Rintoul September 30, 2011 A complaint against former Australian of the Year Patrick McGorry for planning a trial of drugs on children has been dismissed. But the 13 international health experts who lodged the complaint with the ethics committee at Melbourne Health calling for the trial [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-14135","post","type-post","status-publish","format-standard","hentry","category-politics"],"_links":{"self":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/14135","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/comments?post=14135"}],"version-history":[{"count":20,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/14135\/revisions"}],"predecessor-version":[{"id":14157,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/14135\/revisions\/14157"}],"wp:attachment":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/media?parent=14135"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/categories?post=14135"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/tags?post=14135"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}